Anti-Francisella tularensis LPS/Lipopolysaccharide Antibody (11B7)

Catalog No.

RXX02142

Species reactivity

Francisella tularensis

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Target

LPS, Lipopolysaccharide

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ELISA, ICC, IF, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

11B7

Kinetics of the serological response up to one year after tularemia., PMID:36683705

Rapid Detection of Lipopolysaccharide and Whole Cells of Francisella tularensis Based on Agglutination of Antibody-Coated Gold Nanoparticles and Colorimetric Registration., PMID:36557493

Point-of-care vertical flow immunoassay system for ultra-sensitive multiplex biothreat-agent detection in biological fluids., PMID:36257115

Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle., PMID:35275912

Development of Immunoassays for Detection of Francisella tularensis Lipopolysaccharide in Tularemia Patient Samples., PMID:34451388

Critical role of IL-25-ILC2-IL-5 axis in the production of anti-Francisella LPS IgM by B1 B cells., PMID:34449811

Development of an immunoassay test system based on monoclonal antybodies and immunomagnetic particles for the detection of F. tularensis cells., PMID:34105911

Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment., PMID:31388083

Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis., PMID:30872471

[A comparative study of experimental and commercial serological tests for detection of antibodies in humans with tularemia.]., PMID:30768885

Development of dual reporter imaging system for Francisella tularensis to monitor the spatio-temporal pathogenesis and vaccine efficacy., PMID:30112352

Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis lipopolysaccharide., PMID:29630613

Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice., PMID:28774562

A Pathogen-Specific Cargo Delivery Platform Based on Mesoporous Silica Nanoparticles., PMID:28437093

Electrochemiluminescence (ECL) immunosensor for detection of Francisella tularensis on screen-printed gold electrode array., PMID:27255102

Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice., PMID:26853540

Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species., PMID:26438077

Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies., PMID:25999917

Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVS., PMID:25768794

Development of an immunosensor for the detection of Francisella tularensis antibodies., PMID:24817365

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain., PMID:24351755

Antibodies to both terminal and internal B-cell epitopes of Francisella tularensis O-polysaccharide produced by patients with tularemia., PMID:24351753

Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum., PMID:22888138

Chemical synthesis and immunological evaluation of the inner core oligosaccharide of Francisella tularensis., PMID:22867268

Structural analysis of a protective epitope of the Francisella tularensis O-polysaccharide., PMID:22747335

Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia., PMID:22486311

A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides., PMID:22091710

Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity., PMID:21799828

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge., PMID:21750122

Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide., PMID:21466282

Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis., PMID:20625403

Francisella tularensis suppresses the proinflammatory response of endothelial cells via the endothelial protein C receptor., PMID:20543103

Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide o-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy., PMID:21687776

[Experimental verification of a model of complement-dependent immune lysis of liposomes]., PMID:19569506

Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge., PMID:19251656

Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy., PMID:19176692

[Interaction of S- and R-lipopolysaccharides of Francisella tularensis with lypopolysaccharide-binding protein of human serum]., PMID:18819401

Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia., PMID:18614668

Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis., PMID:18505805

Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis., PMID:18307525

Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity., PMID:17960662

Generation and characterization of hybridoma antibodies for immunotherapy of tularemia., PMID:17764754

Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes., PMID:17634278

[Highly sensitive enzyme-linked assay based on monoclonal antibodies for detection of Brucella antigens]., PMID:17523430

Production and characterization of a monoclonal antibody to Francisella tularensis lipopolysaccharide., PMID:17451358

Seroprevalence of brucellosis, tularemia, and yersiniosis in wild boars (Sus scrofa) from north-eastern Germany., PMID:16364020

[Phase variations of Francisella tularensis lipopolysaccharide in human infection and immunization]., PMID:16146218

A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia., PMID:16050523

Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia., PMID:15892173

Lipopolysaccharide microarrays for the detection of antibodies., PMID:15847798

Document Download

Anti-Francisella tularensis LPS/Lipopolysaccharide Antibody (11B7).pdf